Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection
- Author
- CHAMBERS, Thomas J1 ; XIAOFENG FAN2 ; DROLL, Deborah A1 ; HEMBRADOR, Edgardo1 ; SLATER, Tiffany1 ; NICKELLS, Michael W1 ; DUSTIN, Lynn B3 ; DIBISCEGLIE, Adrian M2
[1] Department of Molecular Microbiology and Immunology, St. Louis University School of Medicine, St. Louis, Missouri, United States
[2] Department of Medicine, Division of Gastroenterology and Hepatology, St. Louis University Health Sciences Center, St. Louis, Missouri, United States
[3] Center for the Study of Hepatitis C, The Rockefeller University, New York, New York, United States - Source
Journal of virology. 2005, Vol 79, Num 5, pp 3071-3083, 13 p ; ref : 48 ref
- ISSN
- 0022-538X
- Scientific domain
- Biochemistry, molecular biology, biophysics; Microbiology, infectious diseases; Virology
- Publisher
- American Society for Microbiology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Hépatite virale C Interféron Microbiologie Région variable Traitement Virologie Quasi espèce Appareil digestif pathologie Foie pathologie Infection Virose
- Keyword (en)
- Viral hepatitis C Interferon Microbiology Variable region Treatment Virology Quasispecies Digestive diseases Hepatic disease Infection Viral disease
- Keyword (es)
- Hepatitis virica C Interferón Microbiología Región variable Tratamiento Virología Aparato digestivo patología Hígado patología Infección Virosis
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology / 002A05C Virology / 002A05C10 Miscellaneous
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02G Viral hepatitis
- Discipline
- Infectious pathology Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 16586694
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1128/JVI.79.5.3071-3083.2005 
https://dx.doi.org/10.1128/JVI.79.5.3071-3083.2005
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/JVI.79.5.3071-3083.2005\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Quasispecies heterogeneity within the E1\/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Journal of virology\";s:9:\"\u0000*\u0000stitle\";s:8:\"J. virol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"79\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"3071\";s:8:\"\u0000*\u0000epage\";s:4:\"3083\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-538X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CHAMBERS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Thomas J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"XIAOFENG FAN\";i:1;s:16:\"DROLL, Deborah A\";i:2;s:18:\"HEMBRADOR, Edgardo\";i:3;s:15:\"SLATER, Tiffany\";i:4;s:19:\"NICKELLS, Michael W\";i:5;s:14:\"DUSTIN, Lynn B\";i:6;s:21:\"DIBISCEGLIE, Adrian M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Quasispecies heterogeneity within the E1\/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/JVI.79.5.3071-3083.2005\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Quasispecies heterogeneity within the E1\/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Journal of virology\";s:9:\"\u0000*\u0000stitle\";s:8:\"J. virol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"79\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"3071\";s:8:\"\u0000*\u0000epage\";s:4:\"3083\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-538X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CHAMBERS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Thomas J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"XIAOFENG FAN\";i:1;s:16:\"DROLL, Deborah A\";i:2;s:18:\"HEMBRADOR, Edgardo\";i:3;s:15:\"SLATER, Tiffany\";i:4;s:19:\"NICKELLS, Michael W\";i:5;s:14:\"DUSTIN, Lynn B\";i:6;s:21:\"DIBISCEGLIE, Adrian M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Quasispecies heterogeneity within the E1\/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/JVI.79.5.3071-3083.2005\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/JVI.79.5.3071-3083.2005\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Quasispecies heterogeneity within the E1\/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Journal of virology\";s:9:\"\u0000*\u0000stitle\";s:8:\"J. virol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"79\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"3071\";s:8:\"\u0000*\u0000epage\";s:4:\"3083\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-538X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CHAMBERS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Thomas J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"XIAOFENG FAN\";i:1;s:16:\"DROLL, Deborah A\";i:2;s:18:\"HEMBRADOR, Edgardo\";i:3;s:15:\"SLATER, Tiffany\";i:4;s:19:\"NICKELLS, Michael W\";i:5;s:14:\"DUSTIN, Lynn B\";i:6;s:21:\"DIBISCEGLIE, Adrian M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Quasispecies heterogeneity within the E1\/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/JVI.79.5.3071-3083.2005\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Quasispecies heterogeneity within the E1\/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Journal of virology\";s:9:\"\u0000*\u0000stitle\";s:8:\"J. virol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"79\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"3071\";s:8:\"\u0000*\u0000epage\";s:4:\"3083\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-538X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CHAMBERS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Thomas J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"XIAOFENG FAN\";i:1;s:16:\"DROLL, Deborah A\";i:2;s:18:\"HEMBRADOR, Edgardo\";i:3;s:15:\"SLATER, Tiffany\";i:4;s:19:\"NICKELLS, Michael W\";i:5;s:14:\"DUSTIN, Lynn B\";i:6;s:21:\"DIBISCEGLIE, Adrian M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Quasispecies heterogeneity within the E1\/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1128\/JVI.79.5.3071-3083.2005\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Quasispecies heterogeneity within the E1\/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Journal of virology\";s:9:\"\u0000*\u0000stitle\";s:8:\"J. virol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"79\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:4:\"3071\";s:8:\"\u0000*\u0000epage\";s:4:\"3083\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-538X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CHAMBERS\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Thomas J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"XIAOFENG FAN\";i:1;s:16:\"DROLL, Deborah A\";i:2;s:18:\"HEMBRADOR, Edgardo\";i:3;s:15:\"SLATER, Tiffany\";i:4;s:19:\"NICKELLS, Michael W\";i:5;s:14:\"DUSTIN, Lynn B\";i:6;s:21:\"DIBISCEGLIE, Adrian M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Quasispecies heterogeneity within the E1\/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:33:\"American Society for Microbiology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
